Pelvic Exenteration for Locally Recurrent Rectal Cancer

Radical salvage surgery for locally recurrent rectal cancer (LRRC) — exenterative surgery represents the only potentially curative option for this patient group. Content below is from a textbook reference chapter (ASCRS Ch32 - Locally Recurrent Rectal Cancer), not primary literature. This page is the wiki's first dedicated treatment of LRRC-specific exenteration. See Total Mesorectal Excision (TME) & Sphincter-Sparing Resection's Multivisceral or extended resections section for the related but distinct scenario of exenteration for advanced primary (T4) rectal cancer — that content remains authoritative for the primary-tumor setting and is cross-linked, not duplicated, below.

Framing: LRRC exenteration vs. primary-tumor exenteration

Pelvic exenterative surgery for LRRC is argued to be fundamentally a different operation than exenteration for advanced primary rectal cancer, and all centers performing recurrent rectal cancer surgery should be not just competent but expert in the lateral and posterior pelvic compartments. Advanced primary rectal cancer sometimes breaches the mesorectal fascia into surrounding compartments/ organs (T4). In contrast, almost by definition, local recurrence that develops after adequate proctectomy develops in the extra-mesorectal planes — the pelvic floor muscles, the presacral fascia, and the lateral compartment (including the iliac vessels and piriformis muscle, and deeper neurovascular structures posterolaterally including the sacrospinous and sacrotuberous ligaments). The pelvic floor continues anteriorly, with the obturator internus muscle and ischial/pubic bones as important anatomic landmarks laterally/anteriorly. These are the most difficult surgical planes of the pelvis, compounded by redo-surgery complexity and post-radiotherapy fibrosis — pelvic exenteration for LRRC can be the most challenging of pelvic operations. Complete soft-tissue pelvic exenteration for an advanced primary rectal cancer, while carrying obvious two-stoma quality-of-life implications, remains a relatively straightforward procedure for an experienced exenteration surgeon; it only becomes more challenging when radical perineal resection (complete vaginectomy, perineal urethrectomy ± penectomy) is required.

Isolated iliac nodal and anastomotic recurrences are the simplest to excise and are less common, perhaps still appropriately operated on by the original "TME surgeon" — the mindset of a TME surgeon exploring focally outside their usual anatomic realm in LRRC is, per this chapter, "totally a flawed surgical plan in 2020": this approach is often adequate for advanced primary rectal cancer but will undoubtedly lead to low R0 resection rates in LRRC. R0 resection rates for LRRC have climbed from well below 50% in the mid-2000s to ~70% at specialized centers as the field has adopted an increasingly radical approach to the lateral compartment specifically. In a review of >200 recurrent rectal cancer exenterations at the author's own unit: 49% required total cystectomy, 58% required sacrectomy, 73% involved the lateral compartment (defined as at least complete excision of the internal iliac vasculature), and major lumbosacral or complete sciatic nerve excision was performed in 38% of the cohort.

Patterns of local recurrence and anatomical classification

Multiple LRRC classification systems have been proposed, generally derived from individual units' current surgical expertise/opinions on what constitutes a contraindication to surgery — none work well universally, in part because confusion with the historical gynecological exenteration concept (centered on the uterus) creates disparity in how the anterior/posterior pelvic compartments and the "center" of the classification (for a colorectal surgeon, usually the rectum, anastomosis, or central pelvic-floor scar after APR) are defined. Classification systems for LRRC need to incorporate the extent of local invasion into adjacent organs and neurovascular/bony-pelvis involvement, since these determine both the technical difficulty of achieving R0 resection and the anticipated functional consequences (urological/perineal/vascular/orthopedic reconstruction needs).

Fig. 32.1 — the anatomical compartments of the pelvis: five compartments — central/axial, bilateral lateral (left/right), posterior, and anterior — each subdivided into a supra- or infralevator section relative to the pelvic floor. The pelvic floor and its bony attachments are the core determinants of the author's unit's current LRRC classification system.

Historically, 50% of recurrent tumors operated on are centrally located, arising as peri-anastomotic recurrences of the neorectum or from the rectal scar (after prior APR) — true isolated anastomotic recurrences are unusual in the author's experience. Central tumors may involve the vagina/uterus (women) or prostate/seminal vesicles (men) as well as the urinary bladder (extending into the anterior compartment). In the infralevator anterior compartment of the male, the membranous urethra's course as it exits the prostate must be understood, since this plane is encroached upon during a routine cystectomy — relevant when planning soft-tissue exenteration, particularly after prior APR. Where the tumor extends to the anterior pelvic boundary (pubic rami/symphysis), radical anterior bone resection may be necessary. Posterior recurrences sit on/infiltrate the presacral fascia, the sacrum, and its nerve roots, often necessitating en bloc sacrectomy for clear margins. Lateral compartment recurrences require radical resection of the iliac vasculature, lumbosacral trunk, or sciatic nerve, sidewall muscles, and ligamentous structures.

Patient selection and treatment planning

Detection/confirmation of LRRC is often more difficult than expected — many patients have no luminal tumor component readily identified at endoscopy, and symptoms (if present) are often nonspecific. Confirmation is best by biopsy of radiographically abnormal areas, though the biopsy path can be difficult/dangerous when crossing vessels or bowel loops; in these cases, radiological changes combined with ¹⁸F-FDG-PET uptake may be the best available evidence sufficient to initiate treatment. Once LRRC is confirmed and the patient is a potential exenteration candidate (with metastatic disease either absent or resectable), discussions should begin promptly with patient and family to ensure treatment wishes are appropriately considered — about one in five patients with true isolated pelvic recurrence referred for MDT assessment will choose to pursue only palliative approaches despite being deemed suitable for curative-intent exenteration.

Imaging

PET-CT combined with MRI is the mainstay of LRRC assessment — for excluding metastatic disease and for meticulous surgical planning. PET can identify small metastatic lesions not seen on CT, and helps differentiate post-radiation change from tumor when MRI is equivocal. MRI is important for both confirming recurrence and surgical planning — high positive (100%) and negative (89%) predictive values for LRRC diagnosis — though MRI accuracy declines when delineating infiltration of smaller pelvic sidewall structures. In a review of preoperative MRI in LRRC patients at the author's unit, predicted involvement of the high sacrum or lateral compartment was associated with involved resection margins — on this basis, a more extensive resection should be planned whenever posterior/lateral compartment involvement is possible on MRI, rather than attempting to "shave" a tumor off an involved structure (which risks R1 resection).

Multidisciplinary team assessment

Patient assessment for radical salvage surgery should be conducted by a dedicated MDT, aiming to select appropriate surgical candidates and minimize both non-curative (R2) resections and intraoperatively-aborted operations (occult metastases, unexpectedly unresectable tumor). At the author's center, the MDT process was found to be the determinant of resectability in ~70:30 of referred patients, regardless of whether the exenteration surgeon had already consulted the patient — implying the MDT process is genuinely discriminatory, and that perioperative miscommunication between involved physicians can negatively influence R0 resection rates (per a review of R1 resections at the same unit). A dedicated MDT optimally includes specialist colorectal, urological, orthopedic, vascular, and plastic surgeons; medical and radiation oncologists; a radiologist; a psycho-oncologist; a pain specialist; palliative care; and allied health (care coordinators, stomal therapy nurses, dietitians, psychologists, physiotherapists, research/audit officers). Patient access to referral pathways/pelvic oncology MDTs remains a major issue — Swedish national data found fewer than one-third of LRRC patients were discussed at an MDT prior to exenterative surgery.

Resectability

The definition of "resectable" LRRC has changed significantly in recent decades. In 2020, the indication for extended radical resection is a predicted R0 resection with acceptable anticipated morbidity in an appropriately consented and motivated patient. LRRC infiltrating the lateral pelvic compartment (iliac vessels, major pelvic sidewall nerves) had been considered unresectable until recently — a more radical approach to the lateral compartment over the last decade has led to significant R0-rate improvement for tumors invading major neurovascular structures. By ligating and dividing the internal iliac vessels close to their origin, the surgeon can enter an undissected plane lateral to the vessels on piriformis fascia, allowing en bloc excision of the vessels with the recurrent tumor — R0 resection rate in the lateral compartment has risen from 21% (2008) to 69% (current) at the author's unit, with similar findings from the Karolinska Institute. En bloc resection of the common/external iliac vessels is feasible in selected patients where deemed necessary for tumor effacement/invasion, with R0 rates of 38–58% — arterial graft patency long-term is excellent, but venous graft patency has been suboptimal, so the current policy favors ligation of the common/external iliac vein (without interposition graft insertion) after resection, given the high occlusion/ thrombosis/pulmonary-embolism risk with reconstruction; established venous collaterals in LRRC fortuitously limit venous leg swelling when only ligation is performed.

En bloc resection of the sciatic nerve and/or lumbosacral trunk (for tumors extending more laterally into piriformis) has R0 rates similar to central pelvic tumors and better-than-anticipated functional outcomes. Radical sciatic nerve resection (partial or complete), with or without resection of the sciatic notch, can be done via abdominal-perineal or trans-gluteal/prone access. Almost all patients (96%) requiring complete sciatic nerve resection are able to mobilize postoperatively with intensive physiotherapy/orthotics — a rolling gait using ankle orthotics and knee-locking via quadriceps (femoral nerve) on landing addresses the resultant foot drop. Physical quality of life temporarily declines after sciatic nerve involvement but returns to preoperative baseline within 12 months.

Posterior pelvic compartment tumors generally involve/efface the sacrum and require en bloc sacrectomy for clearance. Low sacrectomy (below S3) is now routine with relatively low complication rates, prone or abdomino-lithotomy. High sacrectomy (transection above S2/S3) remains controversial, though several units have developed experience with this composite technique — a recent international multicenter collaboration demonstrated high sacrectomy can be performed without compromising R0 resection rates or cancer-specific/overall survival, though it's associated with higher blood loss, increased complication risk, and (obviously) more sacral neurological impairment. High sacrectomy should therefore no longer be considered contraindicated, though its added morbidity requires explicit consent-process discussion.

Metastatic disease

Up to 40% of LRRC patients will also have metastatic disease at diagnosis. Salvage pelvic surgery is generally not pursued when metastases are unresectable. Where isolated metastases are resectable, metastasectomy may be performed before or after local salvage surgery, but synchronous metastasectomy is generally avoided. Liver/lung surgery should typically precede exenteration given the longer surgical recovery after pelvic exenteration; delays before metastasectomy are associated with greater cancer-mortality risk. (See Management of Colorectal Cancer Distant Metastases for the fuller liver/lung-metastasis-management framework this consideration draws on.)

Neoadjuvant and intraoperative treatment

Long-course neoadjuvant chemoradiotherapy is recommended before surgery for all LRRC patients who didn't receive neoadjuvant therapy for their primary tumor. Re-irradiation, intraoperative brachytherapy, and adjuvant chemotherapy remain contentious issues in recurrent rectal cancer, addressed by international collaborative efforts but without a determined appropriate balance between additional morbidity and improved local control.

Technical considerations

All salvage operations for LRRC can be considered in three phases:

Dissection phase: begins with abdominal exploration to exclude metastatic disease, including extensive adhesiolysis of the small bowel with meticulous "patience" to minimize enterotomy/ subsequent enteric fistula risk, followed by ureterolysis and operative ureteral catheter drainage if a conduit is planned, and proximal/distal vascular control for planned vessel resection or hemorrhage control. Obliterated pelvic planes are expected given prior mesorectal-plane dissection and radiotherapy-related fibrosis — wider virgin planes circumnavigating the most difficult compartment(s) are the safest approach to a hostile pelvis.
Resection phase: the tumor is excised with all contiguous involved structures, once dissection has proceeded as far as possible with proximal control of bowel, ureters, and vessels.
Reconstruction phase: hemostasis, urinary and/or fecal conduit construction, ureteric/bladder repair. Mesh reconstruction of soft tissue/bone defects and myocutaneous soft-tissue reconstruction may be necessary.

The three-phase plan is guided by a "6 C philosophy" coined by the author's unit's prior fellows: coherent plan, clear exposure, control (proximal and distal), circumnavigate the tumor, constantly reassess progress, and (at all times) be calm.

Preparation and positioning

Safe exenterative surgery relies on intra- and interdisciplinary teamwork: two consultant colorectal surgeons for all cases where long procedures are expected, particularly for synchronous abdominal/ perineal resection involving bone or lateral neurovascular structures; a urological surgeon is required for a conduit in 50% of recurrent rectal cancer cases (with ureteral reimplantation needed in a further 5–10%); orthopedic, plastic, and vascular surgery support is arranged in advance as anticipated. The operative team reviews imaging and revisits the MDT-developed operative plan preoperatively to ensure coherent communication across the team (Fig. 32.4).

The patient is positioned on a nonslip gel mattress in the modified Lloyd-Davies position, with the distal end rolled back (or a rolled towel under the lumbar curve) to raise the pelvis off the table when an abdomino-lithotomy sacrectomy is planned — the gel mattress prevents slippage in steeper Trendelenburg and allows perineal reflection of the gluteal muscles free of the sacrum for transection, supporting the lumbosacral curvature during anesthetic paralysis and limiting postoperative low-back pain. Existing intestinal stomas are covered with an occlusive dressing, and the anus (if present) sutured closed to limit fecal contamination. Stoma sites are marked by the stomal therapist, with skin marking by a plastic surgeon for potential vertical rectus abdominis myocutaneous (VRAM) flap harvest if perineal reconstruction is anticipated (anticipated new stoma sites need to be marked accordingly given the VRAM harvest, Fig. 32.5). Lower limbs are prepped to the knees if vascular reconstruction may be required, allowing access to the groin/thigh for autologous vein graft harvest.

Exploration and preparing the pelvis

Midline laparotomy with meticulous adhesiolysis avoids inadvertent enterotomies. After excluding unanticipated peritoneal/hepatic metastases, the small bowel is excluded from the pelvis (if a bowel loop is involved, it's transected proximally/distally and excised en bloc). Ureters are identified proximally and dissected distally over the pelvic brim, leaving a tissue cuff around each to preserve blood supply — if total cystectomy/ureterectomy is required, ureters are divided as distally as possible to ensure only non-irradiated ureter is preserved for reconstruction. Infant feeding catheters in the proximal cut ureteral ends allow urine-output monitoring during the resection phase and prevent back pressure (acute tubular necrosis risk during long operative times).

Central recurrences

Centrally located tumors not involving the pubic bone, lateral nerves/iliac vessels, or sacrum may be completely excised by "soft tissue" exenteration alone. Posterior dissection commences above the neorectum (if present), freed from the presacral fascia; proceeding anterolaterally, dissection continues in the extra-TME plane, with the vas deferens (men) or round ligament (women) transected after incising the peritoneum over the iliac vessels — the ureter is retracted medially, deep to the peritoneum, giving access to the internal iliac vessels. Named anterior-division branches (uterine artery, superior/inferior vesical arteries) are ligated/divided with corresponding venous tributaries, allowing retraction of the genitourinary organs to expose the obturator fossa/internus muscle; sidewall internal-iliac branches/tributaries (obturator vessels, obturator nerve) become accessible. The obturator vein is ligated carefully since it's friable post-radiotherapy and retracts deep into the bony obturator canal, risking difficult-to-control venous oozing. The endopelvic fascia/levator ani are exposed and more easily resected abdominally under direct vision than via the traditional perineal approach. Anteriorly, the bladder is mobilized in the prepubic plane, and the dorsal venous complex/ urethra ligated/divided — either abdominally (if well clear of the recurrent tumor) or transperineally at the base of the penis (perineal urethrectomy, allowing wider membranous-urethra excision and minimizing bleeding from the dorsal venous complex, which is difficult to control in the abdominal radiated cave of Retzius).

Total cystectomy in women with LRRC invariably coincides with extensive vaginal involvement. Preserving a functioning (radiated) vagina is difficult once the anterior vaginal wall is resected with the urethra. An interlabial radical vaginectomy and cystectomy dissection plane provides a more radical margin and decreases vaginal venous bleeding vs. subtotal radical vaginectomy; preserving the labia majora allows primary closure without a myocutaneous flap, with a more cosmetic appearance than a flap. Neovaginal reconstruction (e.g. using bowel) can be considered at the time of exenteration or later, using preserved labia majora. If the anterior vaginal wall remains with bladder preservation, a myocutaneous flap restores the posterior vaginal half.

The perineal dissection begins with an elliptical incision around the anus/old APR perineal scar, extended to the base of the scrotum or vaginal introitus. Wide skin excision is unnecessary for supralevator-confined tumors, only needed with infralevator skin involvement (more common in recurrent urogenital/anal SCC). After skin incision, wide dissection through the ischiorectal fossae proceeds toward the bony pelvic periphery — coccyx, ischial tuberosities, inferior pubic rami are key landmarks. Soft-tissue excision on the periosteum with high-powered diathermy (with abdominal-surgeon assistance) disconnects the pelvic floor at the bony attachments of the levator plate defined by preoperative MRI. The perineal surgeon approaches this dissection anatomically rather than being abdominal-surgeon-guided, to ensure predetermined MRI surgical margins are actually delivered — as a rule, the more pelvic floor/ligament/bone that can be disconnected and resected under the abdominal surgeon's direct vision, the clearer/better the final combined resection margin. For anterolaterally-extending tumors, the levator is released at its inferior-pubic-rami attachment, with or without deeper obturator internus release; abdominal and perineal surgeons continue dividing the pelvic floor circumferentially until the specimen can be delivered.

Composite pubic bone resection

LRRC centered in the anterior compartment tends to be problematic following prior APR for low rectal tumors in men, involving the periosteum/fascia overlying and involving the pubic bone. Clear resection margins may only be achievable via radical pubic bone excision, requiring both en bloc pubic bone resection and perineal transection of the urethra at the base of the penis — together allowing an anterior margin beyond the pubic bone and membranous urethra. If pubic bone resection isn't required, dissection anterior to the bladder in the space of Retzius proceeds as usual but stops short of the inferior pubic symphysis without transecting the dorsal vein complex. Where pubic bone resection is required, the dissection stops above the point of tumor involvement (partial) or, if total pubic bone resection is required, the prepubic space isn't entered but resected en bloc using an oscillating saw.

Lateral neurovascular resection

En bloc internal iliac vascular resection is necessary for oncological clearance of laterally infiltrating tumors, and also required during high sacrectomy to "float" the common iliac vessels out of the pelvis and protect them during sacral transection from the prone approach (minimizing bleeding). For radiated/fibrosed vessels, starting dissection of the common/external iliac vessels laterally in the plane medial to the psoas muscle (similar to a lateral pelvic node dissection) allows mobility in a virgin surgical plane. Ligation/division of the internal iliac vessels close to their common-iliac origin allows lateral branches/tributaries (gluteal, ascending lumbar vessels) to be ligated and exposes the piriformis muscle, lumbosacral trunk, and sacral nerve roots lying on piriformis — careful identification/ligation of these lateral branches matters, since retraction into the pelvic sidewall if injured can cause major, difficult-to-control bleeding. The nerves lie deep to the piriformis fascia, which needs incising to dissect the nerve roots down to the ischial spine, where the sciatic nerve exits the pelvis posterolaterally. The obturator internus/piriformis muscles can be excised en bloc; if required for a clear margin, the ischial spine can be excised en bloc via osteotome (or Gigli saw), taking care not to go deeper than the sciatic nerve unnecessarily. Once exposed, complete or partial sciatic nerve resection can be performed.

Extension outside the true lateral compartment can involve psoas muscle excision and femoral nerve dissection/resection. The femoral nerve is easiest identified just above the inguinal ligament, lateral to where the external iliac artery becomes the common femoral artery; superiorly, at the psoas origin (L4–L5 vertebral level), the femoral nerve lies between the larger anterior and smaller posterior psoas muscle heads.

Tumors infiltrating/encasing the common or external iliac vessels necessitate vessel resection with reconstruction. Proximal vascular control is first achieved by dissection at or just below the aortic/IVC bifurcation, plus distal external iliac vessel control, before transection. Autologous venous grafts are preferred for reconstruction over synthetic material given graft-infection concerns; bovine pericardium is an alternative interposition material.

Posterior recurrences

LRRC involving the posterior compartment generally involves the presacral fascia, sacrum, and its nerve roots, with composite distal sacrectomy generally required for a clear posterior margin — the prior proctectomy's posterior plane dictates a close relationship to the sacrum above S3 (the pelvic floor muscle originates from S3 down). Abdomino-lithotomy sacrectomy is feasible if the sacral amputation level is below S3, allowing the entire operation in the abdomino-lithotomy position without a prone phase — this preserves vascular control via iliac vessel access and better access to the sciatic nerve as it exits the pelvis more laterally than in the prone position.

In preparing for sacrectomy, circumnavigation of the point of posterior bony fixation is required via circumferential dissection of the anterior/lateral compartments from the abdominal and perineal approaches, leaving the tumor attached only at the sacrum. The abdominal surgeon's posterior dissection (between the neorectum/bladder after prior APR and the presacral fascia) stops above the level of tumor involvement per preoperative MRI. Sacral amputation level is scored intraoperatively with high-powered diathermy, and marked with a metallic sacral pin if a prone sacrectomy is required. Lateral dissection to the ischial spine follows the sacrospinous ligament, transecting it from the spine to free the sacrum before transection. Identification of the lumbosacral trunk, upper sacral nerve roots, and sciatic nerve (as it starts in the thigh) is critical at this stage. The perineal dissection proceeds in the plane posterior to the coccyx, continuing cephalad on the bone releasing the fibrous gluteal-muscle-to-periosteum attachment up to S2 level — a rolled gel-mattress edge or towel under the lumbar groove is essential to free the sacrum posteriorly (otherwise the gluteal muscle/sacral skin/subcutaneous fat are compressed against and inseparable from the sacrum/coccyx under the patient's weight). After freeing the gluteus/overlying skin from bone, the perineal surgeon places an osteotome posterior to the sacrum to protect the post-sacral skin before the abdominal surgeon transects the sacrum transversely with an osteotome and mallet, delivering the specimen through the perineal wound.

Where high sacrectomy (sacral transection at/proximal to the S2/S3 junction) is required, the patient is turned prone in the jackknife position, with an orthopedic spinal surgeon assisting via a longitudinal incision over the sacrum (potentially continuous with the perineal incision). Gluteal muscle attachments are disconnected posteriorly, sacral transection level confirmed by intraoperative fluoroscopy, and a laminectomy performed. Transverse osteotomies are made, and the sacrospinous/ sacrotuberous ligaments transected to allow specimen delivery. The sciatic nerve is preserved where possible, though nerve-root identification is difficult in the prone position even with fluoroscopic vertebral-level confirmation — prior abdominal dissection of the lumbosacral trunk on piriformis (looping the L5/S1 nerve roots before the prone phase) helps confirm their identity and protect them from inadvertent injury.

Where a central recurrence involves the presacral fascia/sacrum at a high level but centrally between the foramina (L5, S1, S2) without deep infiltration into the vertebral body on MRI, anterior cortical sacrectomy is possible via partial-thickness osteotomies around the point of involvement, preserving the sacral nerve roots — this central high cortical resection can continue caudally with full-thickness bone transection en bloc below the sacroiliac joint (S3) level while remaining in the abdomino- lithotomy approach.

Reconstruction

The extent of reconstruction depends on which organs/vessels/soft tissues required resection. Vascular surgery input may be needed for interposition graft reconstruction if complete common/ external iliac artery or vein resection was necessary — reconstruction is performed as soon as possible after vessel transection to reduce limb ischemia time (limb elevation in lithotomy prolongs this risk). Ureteric reimplantation, with or without a Boari flap, is necessary after partial cystectomy. Four options exist for urinary diversion after total cystectomy (Fig. 32.14): isolated ileal conduit + colostomy, isolated colonic conduit + colostomy, separated urine + fecal colostomy ("wet colostomy" variant), and in-continuity colostomy and conduit with a communal exit — choice depends on radiation effects on the small bowel and prior bowel resections, but usually follows local urological preference. Colonic conduits avoid an additional intestinal anastomosis and its leak risk. Urinary reconstruction can be performed simultaneously with primary perineal closure, or after VRAM flap harvest/inset if required.

Postoperative management

Patients undergoing exenterative surgery are routinely admitted to the ICU postoperatively. Total parenteral nutrition commences on postoperative day 0 given the high malnutrition rate in advanced pelvic malignancy and prolonged-ileus risk in this population. Limb observations are required every 4 hours for the first 3 postoperative days after arterial resection/reconstruction, with compression stockings. For urinary conduits, abdominal drain fluid creatinine is checked on days 1 and 5 to detect early urine leaks, with ureteric catheters removed on days 10–14 (with or without prior fluoroscopic contrast imaging to rule out subclinical leaks).

Outcomes

The PelvEx Collaborative (international collaboration between specialist exenteration centers) has published the most recent pooled data for LRRC surgery: 1184 patients. Average LOS was 15 days, with major postoperative complication and reintervention rates of 32% and 10% respectively. R0 resection rate was 55% in the PelvEx study (58% in a separate systematic review). 5-year overall survival between 40% and 50% can be expected with clear resection margins. Data from the author's center found that while a microscopically clear margin predicts lower local recurrence and higher overall survival, margins wider than 0.1mm didn't convey additional survival benefit — challenging the prevailing 1mm-margin-based definition of R0 (based on primary rectal cancer margin conventions).

Approximately 55% of patients undergoing radical salvage surgery for LRRC will develop disease recurrence; a small fraction (14–21%) have local re-recurrence for which further radical surgery may be feasible, but more recur systemically with distant metastatic disease. There are no data reporting neoadjuvant-chemotherapy outcomes specifically in LRRC resection patients; however, chemotherapy may be considered with the intent of reducing systemic-failure risk.

Conclusions

Exenterative surgery represents the only potentially curative option for LRRC patients. Careful patient selection, meticulous planning, and interdisciplinary teamwork are required for the best possible outcome. When approaching the previously dissected and irradiated pelvis, gain proximal and distal control of organs, vessels, and nerves before circumnavigating the most advanced/involved pelvic compartment. Where there's a question of tumor involvement, radically resect the structure in question to avoid a "close shave" and an involved margin. Surgeons operating on LRRC should be comfortable applying this concept to the lateral and posterior pelvic compartments. Systemic failure remains the most common form of recurrence after radical salvage surgery, and methods to reduce recurrence and lower morbidity require further investigation.

Total Mesorectal Excision (TME) & Sphincter-Sparing Resection — the related but distinct scenario of exenteration for advanced primary (T4) rectal cancer, covered in that page's Multivisceral or extended resections section.
Abdominoperineal Resection (APR) — the primary-tumor procedure whose perineal scar/prior dissection plane this page's Central recurrences section repeatedly references as the anatomic starting point for recurrent-disease dissection.
Management of Colorectal Cancer Distant Metastases — the liver/lung metastasis-management framework this page's Metastatic disease section draws on for LRRC patients with synchronous metastases.
Rectal Cancer — staging and the TME/CRM evolution-of-treatment history underlying why LRRC develops in extra-mesorectal (rather than mesorectal) planes.
Presacral Tumors — the anatomically adjacent topic of primary (non-recurrence-related) presacral masses, with some sacrectomy-technique overlap.
Rectourethral Fistula — briefly references pelvic exenteration as a treatment option for complex rectourethral fistula, a related reconstructive scenario.

Open items / gaps

No primary literature yet on any of this chapter's series/collaboratives (the PelvEx Collaborative's pooled dataset, the author's own >200-case unit series, the Swedish national MDT-referral data, the international high-sacrectomy multicenter collaboration) — all textbook-secondary-source-level, per ASCRS Ch32 - Locally Recurrent Rectal Cancer.
No LRRC-specific classification system has achieved universal adoption per this chapter — worth revisiting if a consensus system emerges in later literature.
The chapter explicitly notes no data exist on neoadjuvant chemotherapy specifically for LRRC (distinct from neoadjuvant chemoradiotherapy, which is more established) — a gap rather than a wiki omission.

Colorectal LLM Wiki